Showing 1 - 10 of 6,193
Debates continue to rage about the propriety of pharmaceutical patents, especially as required by the TRIPS Agreement … whether TRIPS is indeed a just law. One can also realize the steps that the major players – both nations and pharmaceutical …
Persistent link: https://www.econbiz.de/10013034855
Currently trademark bullying has become a serious concern for many small businesses that feel as though powerful corporations are abusing aggressive trademark enforcement and litigation techniques to crush genuine competition. No doubt these concerns merit the serious consideration of all...
Persistent link: https://www.econbiz.de/10013085735
Just as AI enables computers to perform increasingly complex tasks, it, however, also raises a host of novel issues at its intersection with the law, including issues for litigants in patent infringement suits. The investment in AI technologies likely will lead to an increase in AI-related...
Persistent link: https://www.econbiz.de/10013314386
Courts and commentators are sharply divided about how to assess “reverse payment” patent settlements under antitrust law. The essential problem is that a PTO-issued patent provides only a probabilistic indication that courts would hold that the patent is actually valid and infringed, and...
Persistent link: https://www.econbiz.de/10014167001
the approach of the rules developed under the Trade-Related Aspects of Intellectual Properties(TRIPs) agreement, balances …
Persistent link: https://www.econbiz.de/10014117358
Persistent link: https://www.econbiz.de/10012433548
Persistent link: https://www.econbiz.de/10011858674
Doha Declaration further clarified and reaffirmed the existing TRIPS flexibilities. This paper argues that India has taken …-Related Aspects of Intellectual Property Rights (TRIPS Agreement), however, included a number of public health flexibilities in order … the lead role in enacting the TRIPS Agreement's substantive and procedural patent flexibilities by introducing unique …
Persistent link: https://www.econbiz.de/10013258010
Persistent link: https://www.econbiz.de/10012433847
The major bone of contention between the developed and developing countries in the TRIPS negotiations was patents for … pharmaceuticals. The US-led developed countries bloc argued in favour of patents for pharmaceuticals amidst opposition from Brazil …, India and other countries. Ample evidence, including patented AZT for HIV/AIDS treatment, showed that patents could make …
Persistent link: https://www.econbiz.de/10013393634